SmallCap Sentinel: It's Good to be a Sell-Out


IRVINE, Calif., Nov. 6, 2007 (PRIME NEWSWIRE) -- "When testing your flagship product in new retail venues, a word that often describes a political turncoat might well be the best news a company or its investors can receive," stated SmallCap Sentinel analyst D.R. Clark. "So when Sweet Success (OTCBB:SWTS), a functional health beverage, received reports that 30% of inventory stocked in a new deal with a leading national chain had already sold-out, the news was both welcomed and indicative of the company's ever-expanding traction in new markets nationwide."

A comprehensive report focusing on beverage maker Sweet Success, and of interest to investors in Jones Soda Company (Nasdaq:JSDA), Cadbury Schweppes PLC (NYSE:CSG), and Leading Brands Inc. (Nasdaq:LBIX) has been published by financial courier StockUpTicks.com and is available free of charge to the investing public at http://stockupticks.com/profiles/5-2-07.html

"The sales come again for the company's rock star, Glucasafe, which supports healthy glucose levels, and was followed by re-orders in most instances," Clark noted. "The company believes that they could see similar results in the remaining 90 stores to be stocked, which suggests they will be tracking record Glucasafe shipments for the fourth quarter of this year."

San Antonio-based Sweet Success Enterprises, Inc. acquired Nestle's original Sweet Success brand in 2002. Nestle generated revenue of $300,000,000 from Sweet Success beverages. The company has re-launched the product line-up to tap into the rapidly growing demand for convenient and nutritious functional beverages.

For more updates on this subject and more register at http://stockupticks.com/register.html

To have your company featured on StockUpTicks.com or SmallCap Sentinel please use the contact info below.

The SmallCap Sentinel logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3664

For more D.R. Clark views on the market and personal finance visit www.ClarkReport.com

These statements have not been evaluated by the FDA. Sweet Success products are not intended to diagnose, treat, cure or prevent disease.

Statements herein contain forward-looking statements and are subject to significant risks and uncertainties affecting results. SmallCap Sentinel/StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect proposed actions and cannot project capabilities, intent, resources, or experience.

All information contained herein is based upon sources believed to be reliable but no representation is made as to accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP isn't an investment advisor and this report isn't investment advice. MP has been paid 325,000 restricted shares by Sweet Success for preparation/distribution of this report and other advertising services over a six-month period. This constitutes a conflict of interest as to MP's ability to remain objective in communication regarding the subject company.



            

Tags


Kontaktdaten